Our findings suggest that the inhibitory effect of CTS against NPC1L1-mediated intestinal cholesterol absorption may be a potential mechanism, contributing to its alleviation of NAFLD in mice. The gene discussed is NPC1L1; the disease is metabolic dysfunction-associated steatotic liver disease.